Lataa...
CAR T cells for infection, autoimmunity and allotransplantation
Chimeric antigen receptors (CARs) have shown remarkable ability to re-direct T cells to target CD19-expressing tumours, resulting in remission rates of up to 90% of individuals with paediatric acute lymphoblastic lymphoma. Lessons learned from these clinical trials of adoptive T cell therapy for can...
Tallennettuna:
| Julkaisussa: | Nat Rev Immunol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6505691/ https://ncbi.nlm.nih.gov/pubmed/30046149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-018-0042-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|